Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
M3 ( (JP:2413) ) has shared an announcement.
M3, Inc. has approved the issuance of share-based remuneration stock options in the form of share acquisition rights to further align employee incentives with the company’s medium- to long-term performance and strengthen shareholder-oriented management. Under the plan, one employee will receive up to 155 stock acquisition rights, each corresponding to 100 common shares, with no cash payment required and an exercise price of 1 yen per share, exercisable between July 1, 2028 and August 21, 2055; the number of underlying shares may be adjusted in the event of share splits or consolidations, underscoring M3’s use of equity incentives as a tool to retain key talent and support long-term value creation for shareholders.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen2760.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. is a Japan-based company listed on the Tokyo Stock Exchange Prime Market that operates in the healthcare and medical information services sector, leveraging digital platforms to provide information and solutions primarily to medical professionals and related stakeholders in Japan and overseas.
Average Trading Volume: 3,649,193
Technical Sentiment Signal: Hold
Current Market Cap: Yen1409.7B
Find detailed analytics on 2413 stock on TipRanks’ Stock Analysis page.